BUZZ-Insulet shares rise as its quarterly results beat expectations

November 4 - ** Shares of medical device manufacturer Insulet PODD.O rose 4.5% in early trading to $161.44

** According to data compiled by London Stock Exchange Group (LSEG), the company reported adjusted earnings per share for the third quarter of $1.99, higher than the analysts’ average estimate of $1.59

** PODD’s revenue for the quarter was $842 million, exceeding the analysts’ average estimate of $832.69 million

** The company stated that sales of Omnipod insulin pumps for the third quarter increased by 19.7%, reaching $836.6 million

** Including the day’s movement, the stock has fallen 43% year-to-date

(To facilitate non-English speakers, Reuters provides its reports automatically translated into several other languages. Because automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the automated translation. The automated translation is provided solely for reader convenience. Reuters assumes no responsibility for any damage or loss arising from the use of the automated translation feature.)